Advertisement
Archival Report| Volume 70, ISSUE 9, P859-865, November 01, 2011

Download started.

Ok

Decreased Fragile X Mental Retardation Protein Expression Underlies Amygdala Dysfunction in Carriers of the Fragile X Premutation

  • David Hessl
    Correspondence
    Address correspondence to David Hessl, Ph.D., University of California-Davis, Departments of Psychiatry and Behavioral Sciences, Medical Investigation of Neurodevelopmental Disorders Institute, 2825 50th Street, Sacramento, CA 95817
    Affiliations
    Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California-Davis, Medical Center, Sacramento, California

    Departments of Psychiatry and Behavioral Sciences, University of California-Davis, Medical Center, Sacramento, California
    Search for articles by this author
  • John M. Wang
    Affiliations
    Center for Mind and Brain, University of California-Davis, Davis, California
    Search for articles by this author
  • Andrea Schneider
    Affiliations
    Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California-Davis, Medical Center, Sacramento, California

    Departments of Psychiatry and Behavioral Sciences, University of California-Davis, Medical Center, Sacramento, California
    Search for articles by this author
  • Kami Koldewyn
    Affiliations
    Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts

    McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts
    Search for articles by this author
  • Lien Le
    Affiliations
    Center for Mind and Brain, University of California-Davis, Davis, California
    Search for articles by this author
  • Christine Iwahashi
    Affiliations
    Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Davis, California
    Search for articles by this author
  • Katherine Cheung
    Affiliations
    Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Davis, California
    Search for articles by this author
  • Flora Tassone
    Affiliations
    Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California-Davis, Medical Center, Sacramento, California

    Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Davis, California
    Search for articles by this author
  • Paul J. Hagerman
    Affiliations
    Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California-Davis, Medical Center, Sacramento, California

    Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Davis, California
    Search for articles by this author
  • Susan M. Rivera
    Affiliations
    Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California-Davis, Medical Center, Sacramento, California

    Department of Psychology, University of California-Davis, Davis, California

    Center for Mind and Brain, University of California-Davis, Davis, California
    Search for articles by this author

      Background

      The fragile X premutation provides a unique opportunity for the study of genetic and brain mechanisms of behavior and cognition in the context of neurodevelopment and neurodegeneration. Although the neurodegenerative phenotype, fragile X-associated tremor/ataxia syndrome, is well described, evidence of a causal link between the premutation and psychiatric disorder earlier in life, clear delineation of a behavioral/cognitive phenotype, and characterization of the physiological basis of observed symptoms have been elusive.

      Methods

      We completed functional magnetic resonance imaging targeting the amygdala with an emotion-matching task and concurrent infrared eye tracking, FMR1 molecular genetic testing, and neuropsychological assessment in 23 men with the premutation (mean age = 32.9 years) and 25 male control subjects (mean age = 30.1 years).

      Results

      Premutation carriers had significantly smaller left and right amygdala volume and reduced right amygdala activation during the task relative to control subjects. Although both elevated FMR1 messenger RNA and reduced fragile X mental retardation protein (FMRP) were associated with the reduced activation, multiple regression analysis suggested that reduced FMRP is the primary factor. Premutation carriers also had higher ratings of autism spectrum symptoms than control subjects, which were associated with the reduced amygdala response.

      Conclusions

      Although prior studies have emphasized a toxic gain-of-function effect of elevated messenger RNA associated with the premutation, the current results point to the role of reduced FMRP in alterations of brain activity and behavior.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sherman S.L.
        Premature ovarian failure in the fragile X syndrome.
        Am J Med Genet. 2000; 97: 189-194
        • Allingham-Hawkins D.J.
        • Babul-Hirji R.
        • Chitayat D.
        • Holden J.J.
        • Yang K.T.
        • Lee C.
        • et al.
        Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study–preliminary data.
        Am J Med Genet. 1999; 83: 322-325
        • Hagerman P.J.
        • Hagerman R.J.
        Fragile X-associated tremor/ataxia syndrome–an older face of the fragile X gene.
        Nat Clin Pract Neurol. 2007; 3: 107-112
        • Schneider A.
        • Hagerman R.J.
        • Hessl D.
        Fragile X syndrome–from genes to cognition.
        Dev Disabil Res Rev. 2009; 15: 333-342
        • Fernandez-Carvajal I.
        • Walichiewicz P.
        • Xiaosen X.
        • Pan R.
        • Hagerman P.J.
        • Tassone F.
        Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population.
        J Mol Diagn. 2009; 11: 324-329
        • Dombrowski C.
        • Levesque S.
        • Morel M.L.
        • Rouillard P.
        • Morgan K.
        • Rousseau F.
        Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles.
        Hum Mol Genet. 2002; 11: 371-378
        • Rousseau F.
        • Rouillard P.
        • Morel M.L.
        • Khandjian E.W.
        • Morgan K.
        Prevalence of carriers of premutation-size alleles of the FMRI gene–and implications for the population genetics of the fragile X syndrome.
        Am J Hum Genet. 1995; 57: 1006-1018
        • Toledano-Alhadef H.
        • Basel-Vanagaite L.
        • Magal N.
        • Davidov B.
        • Ehrlich S.
        • Drasinover V.
        • et al.
        Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
        Am J Hum Genet. 2001; 69: 351-360
        • Moore C.J.
        • Daly E.M.
        • Tassone F.
        • Tysoe C.
        • Schmitz N.
        • Ng V.
        • et al.
        The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
        Brain. 2004; 127: 2672-2681
        • Aziz M.
        • Stathopulu E.
        • Callias M.
        • Taylor C.
        • Turk J.
        • Oostra B.
        • et al.
        Clinical features of boys with fragile X premutations and intermediate alleles.
        Am J Med Genet. 2003; 121B: 119-127
        • Farzin F.
        • Perry H.
        • Hessl D.
        • Loesch D.
        • Cohen J.
        • Bacalman S.
        • et al.
        Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.
        J Dev Behav Pediatr. 2006; 27: S137-S144
        • Goodlin-Jones B.L.
        • Tassone F.
        • Gane L.W.
        • Hagerman R.J.
        Autistic spectrum disorder and the fragile X premutation.
        J Dev Behav Pediatr. 2004; 25: 392-398
        • Borghgraef M.
        • Steyaert J.
        • Deroo S.
        • Maes B.
        • Fryns J.P.
        Preliminary findings in boys with fragile X premutation: Is there a distinct behavioral phenotype?.
        in: Presented at the International Fragile X Conference, Washington, DC; June 23–27, 20042004
        • Bourgeois J.
        • Seritan A.
        • Casillas E.M.
        • Hessl D.
        • Schneider A.
        • Yang Y.
        • et al.
        Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.
        J Clin Psychiatry. 2011; 72: 175-182
        • Bourgeois J.A.
        • Coffey S.M.
        • Rivera S.M.
        • Hessl D.
        • Gane L.W.
        • Tassone F.
        • et al.
        A review of fragile X premutation disorders: Expanding the psychiatric perspective.
        J Clin Psychiatry. 2009; 70: 852-862
        • Hessl D.
        • Tassone F.
        • Loesch D.Z.
        • Berry-Kravis E.
        • Leehey M.A.
        • Gane L.W.
        • et al.
        Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.
        Am J Med Genet B Neuropsychiatr Genet. 2005; 139: 115-121
        • Roberts J.E.
        • Bailey Jr, D.B.
        • Mankowski J.
        • Ford A.
        • Sideris J.
        • Weisenfeld L.A.
        • et al.
        Mood and anxiety disorders in females with the FMR1 premutation.
        Am J Med Genet B Neuropsychiatr Genet. 2009; 150B: 130-139
        • Hessl D.
        • Rivera S.
        • Koldewyn K.
        • Cordeiro L.
        • Adams J.
        • Tassone F.
        • et al.
        Amygdala dysfunction in men with the fragile X premutation.
        Brain. 2007; 130: 404-416
        • Wechsler D.
        Wechsler Adult Intelligence Scale–Third Edition Manual.
        The Psychological Corporation, San Antonio1997
        • Lord C.
        • Rutter M.
        Autism Diagnostic Observation Schedule–WPS Edition.
        Western Psychological Services, Los Angeles1989
        • Constantino J.N.
        • Todd R.D.
        Intergenerational transmission of subthreshold autistic traits in the general population.
        Biol Psychiatry. 2005; 57: 655-660
        • Tassone F.
        • Pan R.
        • Amiri K.
        • Taylor A.K.
        • Hagerman P.J.
        A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.
        J Mol Diagn. 2008; 10: 43-49
        • Filipovic-Sadic S.
        • Sah S.
        • Chen L.
        • Krosting J.
        • Sekinger E.
        • Zhang W.
        • et al.
        A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.
        Clin Chem. 2010; 56: 399-408
        • Tassone F.
        • Hagerman R.J.
        • Taylor A.K.
        • Gane L.W.
        • Godfrey T.E.
        • Hagerman P.J.
        Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome.
        Am J Hum Genet. 2000; 66: 6-15
        • Iwahashi C.
        • Tassone F.
        • Hagerman R.J.
        • Yasui D.
        • Parrott G.
        • Nguyen D.
        • et al.
        A quantitative ELISA assay for the fragile x mental retardation 1 protein.
        J Mol Diagn. 2009; 11: 281-289
        • Zeng H.
        • Constable R.T.
        Image distortion correction in EPI: Comparison of field mapping with point spread function mapping.
        Magn Reson Med. 2002; 48: 137-146
        • Robb R.A.
        The biomedical imaging resource at Mayo Clinic.
        IEEE Trans Med Imaging. 2001; 20: 854-867
        • Robb R.A.
        • Barillot C.
        Interactive display and analysis of 3-D medical images.
        IEEE Trans Med Imaging. 1989; 8: 217-226
        • Robb R.A.
        • Hanson D.P.
        • Karwoski R.A.
        • Larson A.G.
        • Workman E.L.
        • Stacy M.C.
        Analyze: A comprehensive, operator-interactive software package for multidimensional medical image display and analysis.
        Comput Med Imaging Graph. 1989; 13: 433-454
        • Schumann C.M.
        • Hamstra J.
        • Goodlin-Jones B.L.
        • Lotspeich L.J.
        • Kwon H.
        • Buonocore M.H.
        • et al.
        The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages.
        J Neurosci. 2004; 24: 6392-6401
        • Brown S.M.
        • Peet E.
        • Manuck S.B.
        • Williamson D.E.
        • Dahl R.E.
        • Ferrell R.E.
        • et al.
        A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity.
        Mol Psychiatry. 2005; 10: 805
        • Ekman F.
        • Friesen W.
        Pictures of Facial Affect.
        Psychologists Press, Palo Alto, CA1976
        • Tottenham N.
        • Tanaka J.W.
        • Leon A.C.
        • McCarry T.
        • Nurse M.
        • Hare T.A.
        • et al.
        The NimStim set of facial expressions: Judgments from untrained research participants.
        Psychiatry Res. 2009; 168: 242-249
        • Bertolino A.
        • Arciero G.
        • Rubino V.
        • Latorre V.
        • De Candia M.
        • Mazzola V.
        • et al.
        Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style.
        Biol Psychiatry. 2005; 57: 1517-1525
        • Hariri A.R.
        • Mattay V.S.
        • Tessitore A.
        • Kolachana B.
        • Fera F.
        • Goldman D.
        • et al.
        Serotonin transporter genetic variation and the response of the human amygdala.
        Science. 2002; 297: 400-403
        • Friston K.J.
        • Holmes A.P.
        • Worsley J.-P.
        • Poline C.D.
        • Frith C.D.
        • Frackowiak R.S.J.
        Statistical parametric maps in functional imaging: A general linear approach.
        Hum Brain Mapp. 1995; 2: 189-210
        • Genovese C.R.
        • Lazar N.A.
        • Nichols T.
        Thresholding of statistical maps in functional neuroimaging using the false discovery rate.
        Neuroimage. 2002; 15: 870-878
        • Duvernoy H.M.
        • Bourgouin P.
        The Human Brain: Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply.
        Springer, New York1999
        • Holmes A.P.
        • Friston K.J.
        Generalisability, random effects, and population inference.
        Hum Brain Mapp. 1998; 7: S754
        • Brett M.
        • Anton J.L.
        • Valabregue R.
        • Pauline J.B.
        Region of interest analysis using an SPM toolbox.
        Neuroimage. 2002; 16: S497
        • Tzourio-Mazoyer N.
        • Landeau B.
        • Papathanassiou D.
        • Crivello F.
        • Etard O.
        • Delcroix N.
        • et al.
        Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
        Neuroimage. 2002; 15: 273-289
        • Ludwig A.L.
        • Hershey J.W.
        • Hagerman P.J.
        Initiation of translation of the FMR1 mRNA occurs predominantly through 5'-end-dependent ribosomal scanning.
        J Mol Biol. 2011; 407: 21-34
        • Allen E.G.
        • He W.
        • Yadav-Shah M.
        • Sherman S.L.
        A study of the distributional characteristics of FMR1 transcript levels in 238 individuals.
        Hum Genet. 2004; 114: 439-447
        • Tassone F.
        • Beilina A.
        • Carosi C.
        • Albertosi S.
        • Bagni C.
        • Li L.
        • et al.
        Elevated FMR1 mRNA in premutation carriers is due to increased transcription.
        RNA. 2007; 13: 555-562
        • Kenneson A.
        • Zhang F.
        • Hagedorn C.H.
        • Warren S.T.
        Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
        Hum Mol Genet. 2001; 10: 1449-1454
        • Tassone F.
        • Hagerman R.J.
        • Taylor A.K.
        • Hagerman P.J.
        A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.
        J Med Genet. 2001; 38: 453-456
        • Chen L.S.
        • Tassone F.
        • Sahota P.
        • Hagerman P.J.
        The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter.
        Hum Mol Genet. 2003; 12: 3067-3074
        • Peprah E.
        • He W.
        • Allen E.
        • Oliver T.
        • Boyne A.
        • Sherman S.L.
        Examination of FMR1 transcript and protein levels among 74 premutation carriers.
        J Hum Genet. 2010; 55: 66-68
        • Gothelf D.
        • Furfaro J.A.
        • Hoeft F.
        • Eckert M.A.
        • Hall S.S.
        • O'Hara R.
        • et al.
        Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP).
        Ann Neurol. 2008; 63: 40-51
        • Hazlett H.C.
        • Poe M.D.
        • Lightbody A.A.
        • Gerig G.
        • Macfall J.R.
        • Ross A.K.
        • et al.
        Teasing apart the heterogeneity of autism: Same behavior, different brains in toddlers with fragile X syndrome and autism.
        J Neurodev Disord. 2009; 1: 81-90
        • Watson C.
        • Hoeft F.
        • Garrett A.S.
        • Hall S.S.
        • Reiss A.L.
        Aberrant brain activation during gaze processing in boys with fragile X syndrome.
        Arch Gen Psychiatry. 2008; 65: 1315-1323
        • Bear M.F.
        Therapeutic implications of the mGluR theory of fragile X mental retardation.
        Genes Brain Behav. 2005; 4: 393-398
        • Dolen G.
        • Osterweil E.
        • Rao B.S.
        • Smith G.B.
        • Auerbach B.D.
        • Chattarji S.
        • et al.
        Correction of fragile X syndrome in mice.
        Neuron. 2007; 56: 955-962